                         SEQUENCE LISTING

<110>  The Johns Hopkins University
       The Board of Trustees of the Leland Stanford Junior 
       University
 
<120>  METHODS AND MATERIALS FOR TREATING CANCER

<130>  44807-0391WO1

<150>  US 63/214,883
<151>  2021-06-25

<150>  US 63/284,810
<151>  2021-12-01

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  234
<212>  PRT
<213>  artificial

<220>
<223>  CCAR1 polypeptide fragment

<400>  1

Met Ala Gln Phe Gly Gly Gln Lys Asn Pro Pro Trp Ala Thr Gln Phe 
1               5                   10                  15      


Thr Ala Thr Ala Val Ser Gln Pro Ala Ala Leu Gly Val Gln Gln Pro 
            20                  25                  30          


Ser Leu Leu Gly Ala Ser Pro Thr Ile Tyr Thr Gln Gln Thr Ala Leu 
        35                  40                  45              


Ala Ala Ala Gly Leu Thr Thr Gln Thr Pro Ala Asn Tyr Gln Leu Thr 
    50                  55                  60                  


Gln Thr Ala Ala Leu Gln Gln Gln Ala Ala Ala Ala Ala Ala Ala Leu 
65                  70                  75                  80  


Gln Gln Gln Tyr Ser Gln Pro Gln Gln Ala Leu Tyr Ser Val Gln Gln 
                85                  90                  95      


Gln Leu Gln Gln Pro Gln Gln Thr Leu Leu Thr Gln Pro Ala Val Ala 
            100                 105                 110         


Leu Pro Thr Ser Leu Ser Leu Ser Thr Pro Gln Pro Thr Ala Gln Ile 
        115                 120                 125             


Thr Val Ser Tyr Pro Thr Pro Arg Ser Ser Gln Gln Gln Thr Gln Pro 
    130                 135                 140                 


Gln Lys Gln Arg Val Phe Thr Gly Val Val Thr Lys Leu His Asp Thr 
145                 150                 155                 160 


Phe Gly Phe Val Asp Glu Asp Val Phe Phe Gln Leu Ser Ala Val Lys 
                165                 170                 175     


Gly Lys Thr Pro Gln Val Gly Asp Arg Val Leu Val Glu Ala Thr Tyr 
            180                 185                 190         


Asn Pro Asn Met Pro Phe Lys Trp Asn Ala Gln Arg Ile Gln Thr Leu 
        195                 200                 205             


Pro Asn Gln Asn Gln Ser Gln Thr Gln Pro Leu Leu Lys Thr Pro Pro 
    210                 215                 220                 


Ala Val Leu Gln Pro Ile Ala Pro Gln Thr 
225                 230                 


<210>  2
<211>  458
<212>  PRT
<213>  artificial

<220>
<223>  CCAR1 polypeptide fragment

<400>  2

Val Glu Ala Thr Tyr Asn Pro Asn Met Pro Phe Lys Trp Asn Ala Gln 
1               5                   10                  15      


Arg Ile Gln Thr Leu Pro Asn Gln Asn Gln Ser Gln Thr Gln Pro Leu 
            20                  25                  30          


Leu Lys Thr Pro Pro Ala Val Leu Gln Pro Ile Ala Pro Gln Thr Thr 
        35                  40                  45              


Phe Gly Val Gln Thr Gln Pro Gln Pro Gln Ser Leu Leu Gln Ala Gln 
    50                  55                  60                  


Ile Ser Ala Ala Ser Ile Thr Pro Leu Leu Gln Thr Gln Pro Gln Pro 
65                  70                  75                  80  


Leu Leu Gln Gln Pro Gln Gln Lys Ala Gly Leu Leu Gln Pro Pro Val 
                85                  90                  95      


Arg Ile Val Ser Gln Pro Gln Pro Ala Arg Arg Leu Asp Pro Pro Ser 
            100                 105                 110         


Arg Phe Ser Gly Arg Asn Asp Arg Gly Asp Gln Val Pro Asn Arg Lys 
        115                 120                 125             


Asp Asp Arg Ser Arg Glu Arg Glu Arg Glu Arg Arg Arg Ser Arg Glu 
    130                 135                 140                 


Arg Ser Pro Gln Arg Lys Arg Ser Arg Glu Arg Ser Pro Arg Arg Glu 
145                 150                 155                 160 


Arg Glu Arg Ser Pro Arg Arg Val Arg Arg Val Val Pro Arg Tyr Thr 
                165                 170                 175     


Val Gln Phe Ser Lys Phe Ser Leu Asp Cys Pro Ser Cys Asp Met Met 
            180                 185                 190         


Glu Leu Arg Arg Arg Tyr Gln Asn Leu Tyr Ile Pro Ser Asp Phe Phe 
        195                 200                 205             


Asp Ala Gln Phe Thr Trp Val Asp Ala Phe Pro Leu Ser Arg Pro Phe 
    210                 215                 220                 


Gln Leu Gly Asn Tyr Cys Asn Phe Tyr Val Met His Arg Glu Val Glu 
225                 230                 235                 240 


Ser Leu Glu Lys Asn Met Ala Ile Leu Asp Pro Pro Asp Ala Asp His 
                245                 250                 255     


Leu Tyr Ser Ala Lys Val Met Leu Met Ala Ser Pro Ser Met Glu Asp 
            260                 265                 270         


Leu Tyr His Lys Ser Cys Ala Leu Ala Glu Asp Pro Gln Glu Leu Arg 
        275                 280                 285             


Asp Gly Phe Gln His Pro Ala Arg Leu Val Lys Phe Leu Val Gly Met 
    290                 295                 300                 


Lys Gly Lys Asp Glu Ala Met Ala Ile Gly Gly His Trp Ser Pro Ser 
305                 310                 315                 320 


Leu Asp Gly Pro Asp Pro Glu Lys Asp Pro Ser Val Leu Ile Lys Thr 
                325                 330                 335     


Ala Ile Arg Cys Cys Lys Ala Leu Thr Gly Ile Asp Leu Ser Val Cys 
            340                 345                 350         


Thr Gln Trp Tyr Arg Phe Ala Glu Ile Arg Tyr His Arg Pro Glu Glu 
        355                 360                 365             


Thr His Lys Gly Arg Thr Val Pro Ala His Val Glu Thr Val Val Leu 
    370                 375                 380                 


Phe Phe Pro Asp Val Trp His Cys Leu Pro Thr Arg Ser Glu Trp Glu 
385                 390                 395                 400 


Thr Leu Ser Arg Gly Tyr Lys Gln Gln Leu Val Glu Lys Leu Gln Gly 
                405                 410                 415     


Glu Arg Lys Glu Ala Asp Gly Glu Gln Asp Glu Glu Glu Lys Asp Asp 
            420                 425                 430         


Gly Glu Ala Lys Glu Ile Ser Thr Pro Thr His Trp Ser Lys Leu Asp 
        435                 440                 445             


Pro Lys Thr Met Lys Val Asn Asp Leu Arg 
    450                 455             


